News | Oncology Diagnostics | November 18, 2019

Study: AI Found to Reduce Bias in Radiology Reports

The Centre for Advanced Research in Imaging, Neuroscience and Genomics study found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports

 Oxipit ChestEye AI

November 18, 2019 — A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics (CARING) found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer and more actionable diagnosis descriptions. The study was undertaken using Oxipit ChestEye AI imaging suite. Moreover, the study found that nearly 80 percent of the reports generated by Oxipit ChestEye were as accurate as the radiologists' reports and were more accurate in 5 percent of analyzed patient cases.

The study led by Dr. Vasanth Venugopal aimed to identify elements of hedging in clinical radiology reports and evaluate the accuracy and clinical validity of AI-generated reports of chest X-rays. A set of 297 retrospective chest X-ray images was used in the study. The images were analyzed by Oxipit ChestEye and AI generated reports compared to the ones produced by a radiologist. Final report comparison and diagnosis validation was conducted by a radiologist with 9 years of clinical experience. The full study titled “Judging the Accuracy and Clinical Validity of Deep Learning-Generated Test Reports” will be presented at the RSNA conference in Chicago this year.

“Subjectivity is part of human nature. Sometimes radiologists might be fairly confident that there is no pathology in the analyzed case, but they choose to include inconclusive vague diagnosis statements to hedge against potential mistakes or legal threats. On the contrary, AI produces clear, unbiased reports that can help to reassure radiologist in their opinion. A combination of both produces clearer, actionable reports to make treatment decisions, as well as helps to avoid unnecessary procedures resulting from evasive and non-committal reports,” notes Oxipit’ Chief Medical Officer Dr. Naglis Ramanauskas.

Oxipit ChestEye imaging suite encompasses a fully automatic computer aided diagnosis (CAD) platform which supports 75 radiological findings, covering over 90 percent of radiological cases presented to radiologists on a daily basis. ChestEye produces a standardized preliminary text report that incorporates all the radiologically relevant information present in a chest X-ray image, speeding up case description and minimizing the risk of overlooked secondary findings. In February Oxipit ChestEye received CE certification. Internal platform trials showed 30 percent time saved per patient case and reduced error rate by up to 50 percent.

“Oxipit ChestEye was designed as a productivity and second-opinion tool to aid the work of radiologists. The evaluation that nearly 80 percent of preliminary reports generated by our software were clinically accurate to be deemed as final reports, and in 5 percent cases - even more accurate than the ones produced by a radiologist, is an inspiring validation of current capabilities of AI diagnostics,” Ramanauskas said.

In the words of Ramanauskas, even two radiologists can have differing opinions over a particular X-ray report.

“Therefore aiming for 100 percent correlation to radiologist reports is unrealistic. However, with constant improvement of deep learning algorithms and innovations in the medical imaging field, a radiologist working with the help of AI can help to reduce interpersonal subjectivity and greatly increase the quality of the reports while helping the radiologists become more efficient," Ramanauskas said.

For more information: www.caring-research.com 

Related Content

Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...